Safety of radiofrequency ablation in patients with locally advanced, unresectable pancreatic cancer: A phase II study
Volume: 45, Issue: 11, Pages: 2166 - 2172
Published: Nov 1, 2019
Abstract
Radiofrequency ablation (RFA) has been proposed as a new treatment option for locally advanced, unresectable pancreatic cancer (LAPC). In preparation of a randomized controlled trial (RCT), the aim of this phase II study was to assess the safety of RFA for patients with LAPC.Patients diagnosed with LAPC confirmed during surgical exploration between November 2012 and April 2014 were eligible for inclusion. RFA probes were placed under ultrasound...
Paper Details
Title
Safety of radiofrequency ablation in patients with locally advanced, unresectable pancreatic cancer: A phase II study
Published Date
Nov 1, 2019
Volume
45
Issue
11
Pages
2166 - 2172
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History